OUTLOOK THERAPEUTICS, INC. Debt Instrument, Fair Value Disclosure
OUTLOOK THERAPEUTICS, INC. (OTLK) had Debt Instrument, Fair Value Disclosure of $32.23 million as of 2025-12-31, per its 10-Q filed 2026-02-17.
Financial Statements › Notes › Debt Instruments
us-gaap:DebtInstrumentFairValue · last filed 2026-02-17
- 2025-12-31: Debt Instrument, Fair Value Disclosure $32.23M.
- 2025-09-30: Debt Instrument, Fair Value Disclosure $31.45M.
- 2025-06-30: Debt Instrument, Fair Value Disclosure $35.72M.
- 2025-03-31: Debt Instrument, Fair Value Disclosure $35.76M.
| Period end | Debt Instrument, Fair Value Disclosure |
|---|---|
| 2025-12-31 | $32.23M 10-Q · filed 2026-02-17 |
| 2025-09-30 | $31.45M 10-K · filed 2025-12-19 |
| 2025-06-30 | $35.72M 10-Q · filed 2025-08-14 |
| 2025-03-31 | $35.76M 10-Q · filed 2025-05-15 |
| 2024-12-31 | $32.23M 10-Q · filed 2025-02-14 |
| 2024-09-30 | $31.35M 10-K · filed 2024-12-27 |
| 2023-12-31 | $37.67M 10-Q · filed 2024-02-14 |
| 2023-09-30 | $36.76M 10-K · filed 2023-12-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B | |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |